Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants < 33 Weeks

December 7, 2017 updated by: Johns Hopkins University

Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants <33 Weeks: A Randomized Controlled Trial

Anemia in preterm neonates is a significant problem encountered frequently in the neonatal intensive care unit. Most preterm neonates born at less than 33 weeks gestation will require at least one blood transfusion during their hospital course and many will require repeated transfusions. Blood transfusions, albeit necessary, carry increased risk of viral infections and transfusion reactions as well as increase the cost of healthcare. The umbilical cord and placenta harbor up to 40% of blood available during fetal life. The current standard of care is immediate umbilical cord clamping. The investigators are performing a randomized controlled trial comparing immediate cord clamping to milking the umbilical cord prior to clamping in neonate born preterm less than 33 weeks gestation. The investigators hypothesize that milking the umbilical cord will demonstrate the same benefits as delayed cord clamping, without delaying neonatal resuscitation.

Study Overview

Status

Terminated

Conditions

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21287
        • Johns Hopkins Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Preterm neonates delivered between 24 0/7 and 32 6/7
  • Mother carrying a fetus between 24-32 6/7 weeks estimated gestational age
  • Written parental consent

Exclusion Criteria:

  • Multiple gestation pregnancies (twins or higher order multiples)
  • Rh or other antibody sensitization
  • Hydrops fetalis
  • Known major congenital abnormality
  • Suspected abruptio placentae

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Immediate umbilical cord clamping
The umbilical cord will be clamped immediately after delivery.
The umbilical cord will be clamped and cut immediately after delivery of the neonate.
Experimental: Cord milking group
The umbilical cord will be "milked" in direction towards neonate 4 times over the course of 10 minutes.
The umbilical cord will be "milked" toward the neonate four times prior to clamping the umbilical cord.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Hemoglobin during NICU course
Time Frame: within 24 hours of birth and through NICU stay
within 24 hours of birth and through NICU stay

Secondary Outcome Measures

Outcome Measure
Time Frame
Length of hospital stay
Time Frame: 6 months
6 months
1-min Apgar
Time Frame: at 1 minute of life
at 1 minute of life
5 min Apgar
Time Frame: at 5 minutes of life
at 5 minutes of life
Blood Sugar upon admission to NICU
Time Frame: within 1 hour of birth
within 1 hour of birth
Temperature on admission to NICU
Time Frame: within 1 hour of birth
within 1 hour of birth
Cord blood pH
Time Frame: within 1 hour of birth
within 1 hour of birth
Blood pressure upon admission to NICU
Time Frame: within 1 hour of birth
within 1 hour of birth
Number of volume challenges in first 24 hours of life
Time Frame: at 24 hours of birth
at 24 hours of birth
Days requiring ventilation
Time Frame: 2 months
2 months
Neonatal death
Time Frame: 6 months
6 months
Intraventricular hemorrhage
Time Frame: 6 months
6 months
Number and volume of blood transfusions
Time Frame: 10 units
10 units
duration of phototherapy
Time Frame: 1 month
1 month
Maximum serum bilirubin
Time Frame: 1 month
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jessica Bienstock, MD MPH, Johns Hopkins School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2011

Primary Completion (Actual)

October 1, 2013

Study Completion (Actual)

October 1, 2013

Study Registration Dates

First Submitted

October 6, 2011

First Submitted That Met QC Criteria

March 22, 2013

First Posted (Estimate)

March 27, 2013

Study Record Updates

Last Update Posted (Actual)

December 11, 2017

Last Update Submitted That Met QC Criteria

December 7, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prematurity

Clinical Trials on Immediate cord clamping

3
Subscribe